Efficacy of Single dose recombinant HVT-IBDV vaccination (Vaxxitek ®) against classical and variant IBDV strains
Francisco Perozo, Pedro Villegas, Linda Purvis, Rafael Fernandez & Julio Cruz
To assess the protection conferred by day-one vaccination using VAXXITEK®, (a recombinant HVT expressing the VP2 from a classical IBDV), one-day old SPF and/or commercial broilers were vaccinated and then challenged with classical or variant E IBDV strains at 18 or 28 days. Clinical signs, bursa/bodyweight ratio and bursal histopathology were evaluated. No clinical signs or IBDV challenge related lesions were observed in the VAXXITEK® vaccinated birds at both early and late challenge. Unvaccinated challenged birds showed significantly lower bursal indexes. Crossprotection was demonstrated for the variant E challenge. Results indicate that single dose recombinant HVT-IBDV vaccination protects against classical and variant IBDV strains.
Scientific Literature & Other Materials
Want to dig deeper? Browse published research on a range of poultry diseases and products, plus our equipment brochures, website articles, and more.
Product background info, vaccination equipment demos, and customer testimonials—explore all these and others from our video collection.